ENTR-701
- Generic Name
- ENTR-701
A Study of Long-term Safety and Efficacy of VX-670 in Participants With Myotonic Dystrophy Type I
- First Posted Date
- 2025-04-14
- Last Posted Date
- 2025-04-14
- Lead Sponsor
- Vertex Pharmaceuticals Incorporated
- Target Recruit Count
- 36
- Registration Number
- NCT06926621
A Phase 1/2 Study of VX-670 in Adult Participants With Myotonic Dystrophy 1 (DM1)
- First Posted Date
- 2023-12-29
- Last Posted Date
- 2025-04-24
- Lead Sponsor
- Vertex Pharmaceuticals Incorporated
- Target Recruit Count
- 36
- Registration Number
- NCT06185764
- Locations
- 🇧🇪
Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg, Leuven, Belgium
🇫🇷Neuromuscular Reference Center Institute of Myology, Paris, France
🇩🇪Ludwig Maximilians Universitaet Muenchen, Muenchen, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath